Furthermore, in AD, Tau protein propagates itself into the brain via the NLRP3-ASC signal pathway, so the aggregation of Tau protein appears to be more inflammation than Aβ and is associated with the progression of AD symptoms [127], indicating that Tau protein is likely to be the dominant player in neuroinflammation. Here, MAPT is linked to Alzheimer disease.